Baillie Gifford & Co’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-636,136
| Closed | -$3.56M | – | 200 |
|
|
2016
Q3 | $3.56M | Hold |
636,136
| – | – | 0.01% | 185 |
|
|
2016
Q2 | $4.07M | Sell |
636,136
-4,474
| -0.7% | -$28.6K | 0.01% | 176 |
|
|
2016
Q1 | $5.38M | Hold |
640,610
| – | – | 0.01% | 173 |
|
|
2015
Q4 | $6.53M | Sell |
640,610
-1,305
| -0.2% | -$13.3K | 0.01% | 155 |
|
|
2015
Q3 | $7.58M | Sell |
641,915
-6,247
| -1% | -$73.7K | 0.01% | 156 |
|
|
2015
Q2 | $12.6M | Sell |
648,162
-2,854
| -0.4% | -$55.7K | 0.02% | 135 |
|
|
2015
Q1 | $11.6M | Hold |
651,016
| – | – | 0.02% | 138 |
|
|
2014
Q4 | $12M | Hold |
651,016
| – | – | 0.02% | 135 |
|
|
2014
Q3 | $15.8M | Buy |
651,016
+10,257
| +2% | +$248K | 0.03% | 127 |
|
|
2014
Q2 | $23.4M | Buy |
640,759
+52,537
| +9% | +$1.92M | 0.05% | 119 |
|
|
2014
Q1 | $26.9M | Sell |
588,222
-4,705
| -0.8% | -$215K | 0.06% | 114 |
|
|
2013
Q4 | $23.1M | Buy |
592,927
+38,092
| +7% | +$1.48M | 0.05% | 120 |
|
|
2013
Q3 | $25.1M | Buy |
554,835
+76,829
| +16% | +$3.48M | 0.06% | 109 |
|
|
2013
Q2 | $23.5M | Buy |
+478,006
| New | +$23.5M | 0.07% | 104 |
|